← 產業報告目錄
Artificial Intelligence in Cancer Diagnosis and Therapy Market Size, Share & Trends Analysis Report By Surgery Type (Radiotherapy, Chemotherapy, Immunotherapy, Precision Therapy, Phototherapy, Gene Therapy), By Cancer Type, By Application, By Component, By End-User, Region, And Segment Forecasts, 2023-2031.
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-02-18頁數 160報告編號 INSIGHTACE-a718229b3d
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Artificial Intelligence in Cancer Diagnosis and Therapy Market is positioned for steady expansion, with a projected CAGR of 19.2% from 2023 to 2031.
Artificial Intelligence in Cancer Diagnosis and Therapy encompasses The realm of health is just one of many areas of human life where artificial intelligence (AI) has made its way. The sector has gained traction as organizations seek innovative approaches to address evolving technology and communications challenges.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Artificial Intelligence in Cancer Diagnosis and Surgery Type Market Snapshot
Chapter 4. Global Artificial Intelligence in Cancer Diagnosis and Surgery Type Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Surgery Type Estimates & Trend Analysis
5.1. By Surgery Type & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Surgery Type:
5.2.1. Radiotherapy
5.2.2. Chemotherapy
5.2.3. Immunotherapy
5.2.4. Precision Therapy
5.2.5. Phototherapy
5.2.6. Gene Therapy
5.2.7. Sonodynamic Therapy
Chapter 6. Market Segmentation 2: By Cancer Type Estimates & Trend Analysis
6.1. By Cancer Type & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Cancer Type:
6.2.1. Breast Cancer
6.2.2. Lung Cancer
6.2.3. Melanoma Cancer
6.2.4. Colorectal Cancer
6.2.5. Prostate Cancer
6.2.6. Others
Chapter 7. Market Segmentation 3: By End-use Estimates & Trend Analysis
7.1. By End-use & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End-use:
7.2.1. Hospitals
7.2.2. Cancer Research Center
7.2.3. Diagnostic Labs
Chapter 8. Market Segmentation 4: By Component Estimates & Trend Analysis
8.1. By Component & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Component:
8.2.1. Software Solutions
8.2.2. Hardware
8.2.3. Services
Chapter 9. Market Segmentation 5: By Application Estimates & Trend Analysis
9.1. By Application & Market Share, 2019 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application:
9.2.1. Screening & Diagnosis
9.2.2. Tumor Identification
9.2.3. Surveillance
9.2.4. Treatment
Chapter 10. Artificial Intelligence in Cancer Diagnosis and Surgery Type Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) estimates and forecasts By Surgery Type, 2023 - 2031
10.1.2. North America Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) estimates and forecasts By Cancer Type, 2023 - 2031
10.1.3. North America Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) estimates and forecasts by End-use, 2023 - 2031
10.1.4. North America Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) estimates and forecasts by country, 2023 - 2031
10.2. Europe
10.2.1. Europe Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) By Surgery Type, 2023 - 2031
10.2.2. Europe Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) By Cancer Type, 2023 - 2031
10.2.3. Europe Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) estimates and forecasts by End-use, 2023 - 2031
10.2.4. Europe Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) by country, 2023 - 2031
10.3. Asia Pacific
10.3.1. Asia Pacific Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) By Surgery Type, 2023 - 2031
10.3.2. Asia Pacific Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) By Cancer Type, 2023 - 2031
10.3.3. Asia Pacific Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) estimates and forecasts by End-use, 2023 - 2031
10.3.4. Asia Pacific Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) by country, 2023 - 2031
10.4. Latin America
10.4.1. Latin America Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) By Surgery Type, (US$ Million)
10.4.2. Latin America Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) By Cancer Type, (US$ Million)
10.4.3. Latin America Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) estimates and forecasts by End-use, 2023 - 2031
10.4.4. Latin America Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) by country, 2023 - 2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) By Surgery Type, (US$ Million)
10.5.2. Middle East & Africa Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) By Cancer Type, (US$ Million)
10.5.3. Middle East & Africa Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) estimates and forecasts by End-use, 2023 - 2031
10.5.4. Middle East & Africa Artificial Intelligence in Cancer Diagnosis and Surgery Type Market revenue (US$ Million) by country, 2023 - 2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Roche Diagnostics
11.2.2. Pfizer Inc.
11.2.3. IBM Watson Health
11.2.4. CancerCenter.AI
11.2.5. GE Healthcare
11.2.6. Concert AI
11.2.7. Berg
11.2.8. Path AI
11.2.9. Therapixel
11.2.10. iCAD
11.2.11. Sophia Genetics
11.2.12. Janssen Global Services, LLC
11.2.13. JLK Inspection
11.2.14. Median Technologies
11.2.15. Microsoft
11.2.16. Oracle
11.2.17. OhioHealth
11.2.110. Ancora Medical
11.2.111. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們